Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 414

1.

Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study.

Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, Visscher BR, Margolick JB, Dobs AS.

Arch Intern Med. 2005 May 23;165(10):1179-84. Erratum in: Arch Intern Med. 2005 Nov 28;165(21):2541.

PMID:
15911733
2.

Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study.

Tien PC, Schneider MF, Cole SR, Levine AM, Cohen M, DeHovitz J, Young M, Justman JE.

AIDS. 2007 Aug 20;21(13):1739-45.

PMID:
17690572
3.

A comparison of factors associated with prevalent diabetes mellitus among HIV-Infected antiretroviral-naive individuals versus individuals in the National Health and Nutritional Examination Survey cohort.

Brar I, Shuter J, Thomas A, Daniels E, Absalon J; Minorities and Women's Task Force of Terry Beirn Community Programs for Clinical Research on AIDS.

J Acquir Immune Defic Syndr. 2007 May 1;45(1):66-71.

PMID:
17245229
4.

Osteonecrosis of the hip (Legg-Calvé-Perthes disease) in human immunodeficiency virus-infected children.

Gaughan DM, Mofenson LM, Hughes MD, Seage GR 3rd, Ciupak GL, Oleske JM; Pediatric AIDS Clinical Trials Group Protocol 219 Team.

Pediatrics. 2002 May;109(5):E74-4.

PMID:
11986480
5.

Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study.

Lo YC, Chen MY, Sheng WH, Hsieh SM, Sun HY, Liu WC, Wu PY, Wu CH, Hung CC, Chang SC.

HIV Med. 2009 May;10(5):302-9. doi: 10.1111/j.1468-1293.2008.00687.x. Epub 2009 Feb 8.

6.
7.
8.

CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.

McDermott AY, Terrin N, Wanke C, Skinner S, Tchetgen E, Shevitz AH.

Clin Infect Dis. 2005 Dec 1;41(11):1662-70. Epub 2005 Oct 19.

PMID:
16267741
9.

Malignancy in perinatally human immunodeficiency virus-infected children in the United States.

Kest H, Brogly S, McSherry G, Dashefsky B, Oleske J, Seage GR 3rd.

Pediatr Infect Dis J. 2005 Mar;24(3):237-42.

PMID:
15750460
10.

Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women.

Justman JE, Benning L, Danoff A, Minkoff H, Levine A, Greenblatt RM, Weber K, Piessens E, Robison E, Anastos K.

J Acquir Immune Defic Syndr. 2003 Mar 1;32(3):298-302.

PMID:
12626890
11.

Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men.

Brown T, Wang Z, Chu H, Palella FJ, Kingsley L, Witt MD, Dobs AS.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):356-62. Erratum in: J Acquir Immune Defic Syndr. 2007 Jan 1;44(1):119. Chu, Haito [corrected to Chu, Haitao].

PMID:
16980910
12.

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524.

PMID:
18199042
13.

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

Cancer. 2005 Oct 1;104(7):1505-11.

14.

Association of sleep time with diabetes mellitus and impaired glucose tolerance.

Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, Nieto FJ.

Arch Intern Med. 2005 Apr 25;165(8):863-7.

PMID:
15851636
15.

Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.

Brown TT, Li X, Cole SR, Kingsley LA, Palella FJ, Riddler SA, Chmiel JS, Visscher BR, Margolick JB, Dobs AS.

AIDS. 2005 Sep 2;19(13):1375-83.

PMID:
16103768
16.

Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.

Jevtović DO, Salemović D, Ranin J, Pesić I, Zerjav S, Djurković-Djaković O.

HIV Med. 2007 Mar;8(2):75-9.

17.

Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients.

Palacios R, Santos J, García A, Castells E, González M, Ruiz J, Márquez M.

HIV Med. 2006 Jan;7(1):10-5.

18.

Time to virological failure of 3 classes of antiretrovirals after initiation of highly active antiretroviral therapy: results from the EuroSIDA study group.

Mocroft A, Ledergerber B, Viard JP, Staszewski S, Murphy M, Chiesi A, Horban A, Hansen AB, Phillips AN, Lundgren JD; EuroSIDA Study Group.

J Infect Dis. 2004 Dec 1;190(11):1947-56. Epub 2004 Oct 28.

PMID:
15529259
19.

Long-term evaluation of glucose homeostasis in a cohort of HAART-treated HIV-infected children: a longitudinal, observational cohort study.

Viganò A, Brambilla P, Pattarino G, Stucchi S, Fasan S, Raimondi C, Cerini C, Giacomet V, Zuccotti GV, Bedogni G.

Clin Drug Investig. 2009;29(2):101-9. doi: 10.2165/0044011-200929020-00004.

PMID:
19133705
20.

Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003.

Seaberg EC, Muñoz A, Lu M, Detels R, Margolick JB, Riddler SA, Williams CM, Phair JP; Multicenter AIDS Cohort Study.

AIDS. 2005 Jun 10;19(9):953-60.

PMID:
15905677

Supplemental Content

Support Center